XBiotech Historical Financial Ratios
| XBIT Stock | USD 7.61 0.26 3.54% |
XBiotech is currently reporting on over 103 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 14.88, Dividend Yield of 0.18, PTB Ratio of 0.53 or Days Sales Outstanding of 99.29 will help investors to properly organize and evaluate XBiotech financial condition quickly.
XBiotech |
About XBiotech Financial Ratios Analysis
XBiotechFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate XBiotech investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on XBiotech financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across XBiotech history.
XBiotech Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing XBiotech stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on XBiotech sales, a figure that is much harder to manipulate than other XBiotech multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is XBiotech dividend as a percentage of XBiotech stock price. XBiotech dividend yield is a measure of XBiotech stock productivity, which can be interpreted as interest rate earned on an XBiotech investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from XBiotech's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into XBiotech current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.At this time, XBiotech's Stock Based Compensation To Revenue is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.49 in 2024, whereas Days Sales Outstanding is likely to drop 99.29 in 2024.
| 2023 | 2024 (projected) | Dividend Yield | 0.2 | 0.18 | Price To Sales Ratio | 23.98 | 14.88 |
XBiotech fundamentals Correlations
Click cells to compare fundamentals
XBiotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.